Vicarious Surgical (RBOTW) Common Equity (2020 - 2025)

Vicarious Surgical (RBOTW) has 6 years of Common Equity data on file, last reported at $9.8 million in Q4 2025.

• Common Equity for Q4 2025 came in at $9.8 million, down 78.93% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.8 million (down 78.93% YoY), and the FY2025 annual result was $9.8 million, down 78.93% from the prior year.
• Common Equity declined to $9.8 million in Q4 2025 per RBOTW's latest filing, from $14.1 million in the prior quarter.
• Over five years, Common Equity peaked at $129.8 million in Q2 2022 and troughed at -$40.9 million in Q2 2021.
• A 5-year average of $62.7 million and a median of $73.8 million in 2023 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2025: Common Equity jumped 469.16% in 2022, then plunged 78.93% in 2025.
• A 5-year view of Common Equity shows it stood at $83.1 million in 2021, then surged by 33.64% to $111.0 million in 2022, then declined by 11.78% to $98.0 million in 2023, then plunged by 52.33% to $46.7 million in 2024, then sank by 78.93% to $9.8 million in 2025.
• Business Quant data shows RBOTW's Common Equity at $9.8 million in Q4 2025, $14.1 million in Q3 2025, and $23.1 million in Q2 2025.